Development Level

Tbio 2 | 10,625
Tchem 1 | 1,890

IMPC Term

immune system phenotype 1 | 17

Disease

Alzheimer's disease 3 | 644
Cancer 3 | 2,346
malignant mesothelioma 3 | 3,162
Brain Ischemia 2 | 87
Cerebrovascular disease 2 | 231
Inflammation 2 | 109
Multiple Sclerosis 2 | 498
Schizophrenia 2 | 501
Toxic encephalopathy 2 | 131
astrocytoma 2 | 1,493
glioblastoma 2 | 5,572
lung cancer 2 | 4,466
oligodendroglioma 2 | 2,849
ovarian cancer 2 | 8,484
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
psoriasis 2 | 6,685
tuberculosis 2 | 1,557
Acne 1 | 20
Acquired metabolic disease 1 | 267
Alcohol dependence 1 | 107
Amnesia 1 | 17
Amnestic disorder 1 | 37
Amphetamine-Related Disorders 1 | 74
Amyotrophic Lateral Sclerosis 1 | 431
Ankylosing spondylitis 1 | 138
Anorexia nervosa 1 | 59
Anoxia 1 | 33
Anxiety disorder 1 | 22
Arsenic Poisoning 1 | 59
Autistic Disorder 1 | 320
Bacterial vaginosis 1 | 15
Bipolar Disorder 1 | 266
Body Weight 1 | 14
Bulimia nervosa 1 | 15
Cardiomyopathies 1 | 90
Child Development Disorders, Pervasive 1 | 55
Cholesteatoma 1 | 13
Chronic progressive external ophthalmoplegia 1 | 18
Cocaine-Related Disorders 1 | 88
Deafness 1 | 18
Deletion 11p13 1 | 3
Dementia 1 | 129
Depressive disorder 1 | 48
Dermatitis 1 | 107
Dermatitis, Allergic Contact 1 | 66
Dermatologic disorders 1 | 65
Diarrhea 1 | 155
Drug-Induced Liver Injury 1 | 118
End Stage Liver Disease 1 | 4
Epilepsy 1 | 346
Eye disease 1 | 55
Fever 1 | 34
Gingivitis 1 | 19
Glaucoma 1 | 134
Gliosis 1 | 16
Heat Stroke 1 | 12
Hepatic encephalopathy 1 | 25
Heroin dependence 1 | 30
Huntington's disease 1 | 72
Hyperalgesia 1 | 71
Hypercalcemia 1 | 37
Hypotension 1 | 53
Inflammatory bowel disease 1 | 142
Kearns-Sayre syndrome 1 | 6
Kidney disease 1 | 396
Lung disease 1 | 132
MELAS syndrome 1 | 17
MERRF syndrome 1 | 5
Major Depressive Disorder 1 | 106
Metabolic syndrome X 1 | 155
Nerve Degeneration 1 | 73
Neuropathy 1 | 210
Non-alcoholic Fatty Liver Disease 1 | 40
Obesity, Morbid 1 | 6
Opiate dependence 1 | 12
Panic disorder 1 | 55
Parkinson Disease 1 | 102
Parkinson's disease 1 | 364
Peripheral Neuropathy 1 | 303
Pontocerebellar hypoplasia 1 | 29
Psychotic Disorders 1 | 20
Reperfusion Injury 1 | 84
Schizoaffective disorder 1 | 33
Seizures 1 | 95
Sensorineural hearing loss 1 | 107
Skin Neoplasms 1 | 49
Status Epilepticus 1 | 85
Stomach Neoplasms 1 | 282
Substance Withdrawal Syndrome 1 | 52
Substance abuse 1 | 55
Tonic-clonic epilepsy 1 | 47
WAGR syndrome 1 | 12
atypical teratoid/rhabdoid tumor 1 | 1,095
hemolytic-uremic syndrome 1 | 28
interstitial lung disease 1 | 291
nervous system disorder 1 | 53
obsessive-compulsive disorder 1 | 34
post-traumatic stress disorder 1 | 45
substance-related disorder 1 | 105

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Urinary Tract 3 | 18,444
Skin and soft tissues 2 | 18,115

Target Family

Non-IDG 3 | 11,971

Grant Application

1F32MH076320-01 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin-1 alpha IL1A Tchem Non-IDG -3.55666 3644.8 810
Putative peripheral benzodiazepine receptor-related protein TSPO Tbio Non-IDG -3.29377 2078.3 186
Brain-derived neurotrophic factor BDNF Tbio Non-IDG -3.94336 9826.7 594